Michael F. Press, MD, PhD - Best Practices in HER2 Testing for Breast Cancer
Best Practices in HER2 Testing for Breast Cancer
View ArticleMichael F. Press, MD, PhD - Challenging Cases in HER2 Testing
Challenging Cases in HER2 Testing
View ArticleRavi Salgia, MD, PhD - The Promise of the MET Signaling Pathway in Cancer
The Promise of the MET Signaling Pathway in Cancer
View ArticleKathy D. Miller, MD - Individualizing Chemotherapy in Advanced Breast Cancer:...
Individualizing Chemotherapy in Advanced Breast Cancer: Considering Patient Subtypes and Evaluating the Benefits, Risks, and Quality-of-Life Impact of Treatments
View ArticleEdward J. Septimus, MD - Confronting the Mounting Challenge of Drug-Resistant...
Confronting the Mounting Challenge of Drug-Resistant Gram-Negative Nosocomial Infections in the Acute Care Setting
View ArticleAnjali Saqi, MD - Current Perspectives and Emerging Directions in Molecular...
Current Perspectives and Emerging Directions in Molecular Testing for Lung Cancer
View ArticleJohn Mascarenhas, MD - The Hematology-Oncology Team in Myelofibrosis: Best...
The Hematology-Oncology Team in Myelofibrosis: Best Practices for Enhancing Patient Care
View ArticleEdith A. Perez, MD - The "Golden Age" of HER2-Targeted Therapy for Breast...
The "Golden Age" of HER2-Targeted Therapy for Breast Cancer: Translating Evidence to Practice to Improve Outcomes in Early-Stage and Advanced HER2-Positive Disease
View ArticleJohanna C. Bendell, MD - New Science in Gastrointestinal Cancers: What the...
New Science in Gastrointestinal Cancers: What the Latest Updates Mean for the Practicing Oncologist
View ArticleRobert S. Gaston, MD - Immunosuppression for Kidney Transplant Recipients:...
Immunosuppression for Kidney Transplant Recipients: How to Maximize Outcomes and Minimize Graft Failure
View Article
